Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases

Affiliations

• ¹ Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany (S.K., M.G., U.H.); Stem Cell Pathologies Group, Institute of Reconstructive Neurobiology, Bonn, Germany (S.K., L.R, B.S., M.G.); Center of Integrated Oncology (CIO), Universities of Cologne and Bonn, Germany (S.K., N.G., M.S., U.H., M.G.); Department of Neurology, University of Cologne, Cologne, Germany (N.G.), Institute of Neuroscience and Medicine, Forschungszentrum Jülich, Jülich, Germany (N.G., K-J.L.); Department of Dermatology, University of Cologne, Cologne, Germany (M.S.); Neuroradiology, Department of Radiology, University of Bonn Medical Center, Bonn, Germany (E.H.); Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn Medical Center, Bonn, Germany (J.L.); Department of Nuclear Medicine, University of Bonn Medical Center, Bonn, Germany (R.A.B.); Dept. of Nuclear Medicine, University of Aachen, Aachen, Germany (K-J.L.); DKFZ-Division of Translational Oncology / Neurooncology, German Cancer Consortium (DKTK) & University Hospital Essen, Essen, Germany (B.S.); Clinical Cooperation Unit Neurooncology, MediClin Robert Janker Klinik, Bonn, Germany (M.G.).
• ² Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany (S.K., M.G., U.H.); Stem Cell Pathologies Group, Institute of Reconstructive Neurobiology, Bonn, Germany (S.K., L.R, B.S., M.G.); Center of Integrated Oncology (CIO), Universities of Cologne and Bonn, Germany (S.K., N.G., M.S., U.H., M.G.); Department of Neurology, University of Cologne, Cologne, Germany (N.G.), Institute of Neuroscience and Medicine, Forschungszentrum Jülich, Jülich, Germany (N.G., K-J.L.); Department of Dermatology, University of Cologne, Cologne, Germany (M.S.); Neuroradiology, Department of Radiology, University of Bonn Medical Center, Bonn, Germany (E.H.); Laboratory of Experimental Dermatology, Department of Dermatology and Allergy, University of Bonn Medical Center, Bonn, Germany (J.L.); Department of Nuclear Medicine, University of Bonn Medical Center, Bonn, Germany (R.A.B.); Dept. of Nuclear Medicine, University of Aachen, Aachen, Germany (K-J.L.); DKFZ-Division of Translational Oncology / Neurooncology, German Cancer Consortium (DKTK) & University Hospital Essen, Essen, Germany (B.S.); Clinical Cooperation Unit Neurooncology, MediClin Robert Janker Klinik, Bonn, Germany (M.G.) Martin.Glas@ukb.uni-bonn.de.